Strategic Research Programme: Cancer Cell Targeting in Myeloma and Melanoma (MyMe)

Vanderkerken, Karin (Administrative Promotor)
Thielemans, Kris (Administrative Promotor)
Vanderkerken, Karin (Co-Promotor)
Breckpot, Karine (Co-Promotor)

Description

Anti-tumor vaccination requires the identification of target antigens on resistant tumor subpopulations, adequate immune competence of the patients and the availability of efficient vaccination techniques.

Acronym	SRP48
Status	Active
Effective start/end date	1/11/17 → 31/10/24

View all

View less

Flemish discipline codes

Cancer therapy

Keywords

Dendritic Cells
Tonic Pain
Evoked Potentials
Bispecific Antibodies
Immunotherapy
Immunology
Oncology

59 Article
10 Unpublished abstract
2 Poster
2 Scientific review

Assessing Tumor-Infiltrating Lymphocytes in Breast Cancer: A Proposal for Combining Immunohistochemistry and Gene Expression Analysis to Refine Scoring
Locy, H., Verhulst, S., Cools, W., Waelput, W., Brock, S., Cras, L., Schiettecatte, A., Jonckheere, J., van Grunsven, L. A., Vanhoeij, M., Thielemans, K. & Breckpot, K., 11 Feb 2022, In: Frontiers in Immunology. 13, 794175.
Research output: Contribution to journal › Article › peer-review

Open Access
File
3 Citations (Scopus)

40 Downloads (Pure)
T-cell subsets in the skin and their role in inflammatory skin disorders
Kortekaas Krohn, I., Aerts, J. L., Breckpot, K., Goyvaerts, C., Knol, E., Van Wijk, F. & Gutermuth, J., Mar 2022, In: Allergy. 77, 3, p. 827-842 16 p.
Research output: Contribution to journal › Scientific review › peer-review

Open Access
File
6 Citations (Scopus)

60 Downloads (Pure)
A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma
Nylund, P., Atienza Párraga, A., Haglöf, J., De Bruyne, E., Menu, E., Garrido-Zabala, B., Ma, A., Jin, J., Öberg, F., Vanderkerken, K., Kalushkova, A. & Jernberg-Wiklund, H., 12 Feb 2021, In: Cell & Death Disease. 12, 2, 16 p., 167.
Research output: Contribution to journal › Article › peer-review

Open Access
File
8 Citations (Scopus)

138 Downloads (Pure)

1 Finished

SRP14: SRP (Zwaartepunt): Targeting residual cancer cells: myeloma and melanoma as model diseases
Thielemans, K. & Vanderkerken, K.
1/11/12 → 31/10/17
Project: Fundamental

1 Talk or presentation at a workshop/seminar

Noninvasive imaging and inhibition of human programmed death ligand 1 using nanobody K2 to improve cancer immunotherapy
Karine Breckpot (Speaker)
15 Nov 2021
Activity: Talk or presentation › Talk or presentation at a workshop/seminar

Strategic Research Programme: Cancer Cell Targeting in Myeloma and Melanoma (MyMe)

Project Details

Description

Flemish discipline codes

Keywords

Research output

Assessing Tumor-Infiltrating Lymphocytes in Breast Cancer: A Proposal for Combining Immunohistochemistry and Gene Expression Analysis to Refine Scoring

T-cell subsets in the skin and their role in inflammatory skin disorders

A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma

Projects

SRP14: SRP (Zwaartepunt): Targeting residual cancer cells: myeloma and melanoma as model diseases

Activities

Noninvasive imaging and inhibition of human programmed death ligand 1 using nanobody K2 to improve cancer immunotherapy